Hints and tips:
...The active ingredient is used in La Roche Posay’s Lipikar Eczema Med cream....
...The deal will not lead to a change of control at the company, with the voting power of the Hoffman-La Roche family pool increasing to about 67.5 per cent....
...Nice sparked controversy las week by rejecting Roche’s Kadcyla breast cancer drug, which typically extends a patient’s life by about six months at a cost of £90,000....
...After all, as service, aka consumer experience, increasingly becomes a defining factor in luxury, especially in newer markets such as China and Brazil, hiring people who understand what this means, from...
...AUO’s $500m fine equals the record penalty for price-fixing in the US, set in a 1999 case against Swiss healthcare company F Hoffman-La Roche, which settled allegations it colluded to fix vitamin prices....
...But Hoffman-La Roche’s discovery of tranquillisers put that company in pole position among the pharmaceutical companies of continental Europe....
...Alexandra Hauber of Bear Sterns said pharmaceutical stocks had suffered disproportionately during the recent market sell-off and that Novartis, Merck, up 0.8 per cent at €92.70, and Roche, 0.9 per cent firmer...
...Microsoft, 2004 - €497.2m Hoffman-La Roche, 2001 - €462m BASF, 2001 - €296.16m Lafarge, 2002 - €249.60m Arkema, 2006 - €219.13m Arjo Wiggins, 2001 - €184.27m Solvay, 2006 - €167.062m Nintendo, 2002...
...Novartis still has its stake but is blocked from doing much by Roche’s controlling Hoffman family....
...Roche, in which Novartis holds a 33 per cent stake, rose 2.1 per cent to SFr124.30....
International Edition